Search

Michael C. Henry

Examiner (ID: 15985, Phone: (571)272-0652 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1673
Total Applications
1225
Issued Applications
607
Pending Applications
85
Abandoned Applications
536

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14963233 [patent_doc_number] => 20190309095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => Synthetic Oligosaccharide Subunits Of The PSL Exopolysaccharide Of Pseudomonas Aeruginosa And Uses Thereof [patent_app_type] => utility [patent_app_number] => 16/219199 [patent_app_country] => US [patent_app_date] => 2018-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219199 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/219199
Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof Dec 12, 2018 Issued
Array ( [id] => 16435655 [patent_doc_number] => 20200352980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => GLYCAN PREPARATIONS FOR THE TREATMENT OF INFECTION [patent_app_type] => utility [patent_app_number] => 16/761093 [patent_app_country] => US [patent_app_date] => 2018-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -125 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/761093
GLYCAN PREPARATIONS FOR THE TREATMENT OF INFECTION Nov 2, 2018 Abandoned
Array ( [id] => 15290845 [patent_doc_number] => 20190388558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => KARTOGENIN DERIVATIVE-CONTAINING POLYMERIC MICELLE, HYALURONIC ACID HYDROGEL, METHOD FOR PRODUCING THE SAME, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/174902 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174902 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/174902
KARTOGENIN DERIVATIVE-CONTAINING POLYMERIC MICELLE, HYALURONIC ACID HYDROGEL, METHOD FOR PRODUCING THE SAME, AND USE THEREOF Oct 29, 2018 Abandoned
Array ( [id] => 16252109 [patent_doc_number] => 20200261483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/760317 [patent_app_country] => US [patent_app_date] => 2018-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6968 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760317 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760317
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Oct 28, 2018 Abandoned
Array ( [id] => 17207747 [patent_doc_number] => 11168106 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-11-09 [patent_title] => Synthesis and stabilization of nicotinamide ribose and its derivatives [patent_app_type] => utility [patent_app_number] => 16/160189 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2333 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160189 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/160189
Synthesis and stabilization of nicotinamide ribose and its derivatives Oct 14, 2018 Issued
Array ( [id] => 17952421 [patent_doc_number] => 11478494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Methods and substances for prevention and treatment of neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 16/754426 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8675 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754426 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754426
Methods and substances for prevention and treatment of neurodegenerative diseases Oct 14, 2018 Issued
Array ( [id] => 16025741 [patent_doc_number] => 10675270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Chondroitin complexes for transcutaneous absorption [patent_app_type] => utility [patent_app_number] => 16/124269 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5836 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124269 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/124269
Chondroitin complexes for transcutaneous absorption Sep 6, 2018 Issued
Array ( [id] => 17349991 [patent_doc_number] => 11224609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Mithramycin derivatives having increased selectivity and anti-cancer activity [patent_app_type] => utility [patent_app_number] => 16/122655 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 18888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122655 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/122655
Mithramycin derivatives having increased selectivity and anti-cancer activity Sep 4, 2018 Issued
Array ( [id] => 16976142 [patent_doc_number] => 20210220379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS [patent_app_type] => utility [patent_app_number] => 16/642989 [patent_app_country] => US [patent_app_date] => 2018-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11777 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642989
PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS Aug 29, 2018 Abandoned
Array ( [id] => 13837579 [patent_doc_number] => 20190022274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => FORMATION OF SEMI-PERMEABLE POROUS ARTIFICIAL SCAB [patent_app_type] => utility [patent_app_number] => 16/115874 [patent_app_country] => US [patent_app_date] => 2018-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1332 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115874 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/115874
FORMATION OF SEMI-PERMEABLE POROUS ARTIFICIAL SCAB Aug 28, 2018 Abandoned
Array ( [id] => 15524703 [patent_doc_number] => 20200054657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => Compositions of Matter and Methoods to Treat Cancer [patent_app_type] => utility [patent_app_number] => 15/999295 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999295 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/999295
Compositions of Matter and Methoods to Treat Cancer Aug 19, 2018 Abandoned
Array ( [id] => 13826525 [patent_doc_number] => 20190016747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => PURIFIED REBAUDIOSIDE A [patent_app_type] => utility [patent_app_number] => 16/103818 [patent_app_country] => US [patent_app_date] => 2018-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103818 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/103818
PURIFIED REBAUDIOSIDE A Aug 13, 2018 Abandoned
Array ( [id] => 13574983 [patent_doc_number] => 20180339040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => POLYSACCHARIDE SUITABLE TO MODULATE IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 16/054849 [patent_app_country] => US [patent_app_date] => 2018-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/054849
Polysaccharide suitable to modulate immune response Aug 2, 2018 Issued
Array ( [id] => 15435347 [patent_doc_number] => 20200031857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => ANION EXCHANGE STATIONARY PHASES BASED ON A POLYALKYLPOLYAMINE POLYMER LAYER [patent_app_type] => utility [patent_app_number] => 16/049464 [patent_app_country] => US [patent_app_date] => 2018-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049464 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/049464
ANION EXCHANGE STATIONARY PHASES BASED ON A POLYALKYLPOLYAMINE POLYMER LAYER Jul 29, 2018 Abandoned
Array ( [id] => 16868475 [patent_doc_number] => 20210161942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => GLYCAN COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/630116 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -155 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630116 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630116
GLYCAN COMPOSITIONS AND METHODS OF USE Jul 12, 2018 Abandoned
Array ( [id] => 15960465 [patent_doc_number] => 20200163984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => USE OF ISOVALERYL SPIRAMYCIN I, II AND/OR III IN MANUFACTURING MEDICAMENT FOR TREATING AND/OR PREVENTING TUMOR, AND MEDICAMENT [patent_app_type] => utility [patent_app_number] => 16/627102 [patent_app_country] => US [patent_app_date] => 2018-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627102 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627102
USE OF ISOVALERYL SPIRAMYCIN I, II AND/OR III IN MANUFACTURING MEDICAMENT FOR TREATING AND/OR PREVENTING TUMOR, AND MEDICAMENT Jul 3, 2018 Abandoned
Array ( [id] => 17845124 [patent_doc_number] => 11434480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Viral RNA extracting composition and viral RNA extracting method [patent_app_type] => utility [patent_app_number] => 16/343071 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5829 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343071 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/343071
Viral RNA extracting composition and viral RNA extracting method May 24, 2018 Issued
Array ( [id] => 16012899 [patent_doc_number] => 20200181292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => NOVEL WATER-SOLUBLE NATURAL POLYSACCHARIDE ANTIBACTERIAL MATERIAL AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/629881 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/629881
NOVEL WATER-SOLUBLE NATURAL POLYSACCHARIDE ANTIBACTERIAL MATERIAL AND PREPARATION METHOD THEREOF May 23, 2018 Abandoned
Array ( [id] => 15618823 [patent_doc_number] => 20200079816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => COBALAMIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISEASES CAUSED BY LACK OF VITAMIN B12 SUPPLY [patent_app_type] => utility [patent_app_number] => 16/615014 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615014 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615014
Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply May 23, 2018 Issued
Array ( [id] => 18186366 [patent_doc_number] => 11576924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Compounds for the prevention and treatment of diseases and the use thereof [patent_app_type] => utility [patent_app_number] => 16/611609 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 27 [patent_no_of_words] => 22613 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611609 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611609
Compounds for the prevention and treatment of diseases and the use thereof May 10, 2018 Issued
Menu